Advertisement
Oral medicine| Volume 104, ISSUE 4, P491-496, October 2007

Oromandibular dystonia

      Oromandibular dystonia (OMD) is a rare neuromuscular disorder characterized by involuntary repetitive muscular contraction affecting different parts of the oromandibular region. Its various physical manifestations can be extremely debilitating and socially disabling to affected patients. To date, there is no commonly accepted set of diagnostic criteria nor well-defined management pathways. This paper aims to discuss some aspects of clinical manifestations, diagnostic criteria, neurological mechanisms, and treatment options for OMD, with illustrations from 6 clinical cases.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      References

      1. Kumar P. Clark M. Clinical medicine. 6th ed. Saunders, Philadelphia, PA2005: 1227
        • Blanchet P.J.
        • Rompre P.H.
        • Lavigne G.J.
        • Lamarche C.
        Oral dyskinesia: a clinical overview.
        Inter J Prosth. 2005; 18: 10-19
        • Fahn S.
        Concept and classification of dystonia.
        Adv Neurol. 1988; 50: 1-8
        • Scott B.L.
        Evaluation and treatment of dystonia.
        South Med J. 2000; 93: 746-751
        • Tintner R.
        • Jankovic J.
        Botulinum toxin type A in the management of oromandibular dystonia and bruxism.
        in: Scientific and therapeutic aspects of Botulinum toxin. Lippincott Williams & Wilkins, Philadelphia, PA2002: 1-12
      2. American Association of Neurological Surgeons. Available from: NeurosurgeryToday.org. Accessed December 2006.

        • Tan E.K.
        • Jankovic J.
        Tardive and idiopathic oromandibular dystonia: a clinical comparison.
        J Neurol Neurosurg Psychiatry. 2000; 68: 186-190
        • Sankhla C.
        • Lai E.C.
        • Jankovic J.
        Peripherally induced oromandibular dystonia.
        J Neurol Neurosurg Psychiatry. 1998; 65: 722-728
        • Blanchet P.J.
        • Abdillahi O.
        • Beauvais C.
        • Rompre P.H.
        • Lavigne G.J.
        Prevalence of spontaneous oral dyskinesia in the elderly: a reappraisal.
        Mov Disord. 2004; 19: 892-896
        • Jankovic J.
        • Van der Linden C.
        Dystonia and tremor induced by peripheral trauma: predisposing factors.
        J Neurol Neurosurg Psychiatry. 1988; 41: 1088-1091
        • Jankovic J.
        • Leder S.
        • Warner D.
        • Schwartz K.
        Cervical dystonia: clinical findings and associated movement disorders.
        Neurology. 1991; 41: 1088-1091
        • Yoshida K.
        Muscle afferent block in the treatment of oromandibular dystonia.
        Nervenartz. 2003; 74: 516-522
        • Hallett M.
        Is dystonia a sensory disorder?.
        Ann Neurol. 1995; 38: 139-141
        • Schrag A.
        • Bhatia K.P.
        • Quinn N.P.
        • Marsden C.D.
        Atypical and typical cranial dystonia following dental procedures.
        Move Dis. 1999; 14: 492-496
        • Williams D.T.
        • Ford B.
        • Fahn S.
        Phenomenology and psychopathology related to psychogenic movement disorders.
        Adv Neurol. 1995; 65: 231-257
        • Lang A.E.
        Psychogenic dystonia: a review of 18 cases.
        Can J Neurol Sci. 1995; 22: 136-143
        • Fahn S.
        • Williams D.T.
        Psychogenic dystonia.
        Adv Neurol. 1988; 50: 431-455
        • Hanagasi H.A.
        • Bilgic B.
        • Gurvit H.
        • Emre M.
        Clozapine treatment in oromandibular dystonia.
        Clin Neuropharmacol. 2004; 27: 84-86
        • Janovic J.
        Medical therapy and botulinum toxin in dystonia.
        Adv Neurol. 1998; 78: 169-183
        • Tan E.K.
        • Chan L.L.
        • Wong M.C.
        Levodop-induced oromandibular dystonia in progressive supranuclear palsy.
        Clin Neurol Neurosurg. 2003; 105: 132-134
        • Yoshida K.
        • Kaji R.
        • Shibasaki H.
        • Iizuka T.
        Factors influencing the therapeutic effect of muscle afferent block for oromandibular dystonia and dyskinesia.
        Int J Oral Maxillofac Surg. 2002; 31: 499-505
        • Naumann M.
        • Magyar-Lehmann S.
        • Reiners K.
        • Erbguth F.
        • Leenders K.L.
        Sensory tricks in cervical dystonia: perceptual dysbalance of parietal cortex modulates frontal motor programming.
        Ann Neurol. 2001; 47: 322-328